Alterations of colonic sensitivity and gastric dysmotility after acute cisplatin and granisetron
[Background] Cisplatin is a highly emetogenic antineoplastic drug and induces peripheral neuropathy when given in cycles. Granisetron, a 5-HT3 antagonist, is clinically used to prevent chemotherapy-induced nausea/emesis and abdominal pain in irritable bowel syndrome. The effects of cisplatin on visceral sensitivity and those of granisetron in the context of cancer chemotherapy are not well known. [Methods] Adult male Wistar rats received two intraperitoneal injections 30 minutes apart: granisetron (1 mg kg)/vehicle and cisplatin (6 mg kg)/vehicle. Thereafter, nausea-like behavior was measured as bedding intake for 4 hours, and gastric dysmotility was measured radiographically for 8 hours. Gastric weight and size were determined ex vivo and samples of the forestomach, corpus, ileum, and colon were obtained for histological analysis at 4 and 30 hours after cisplatin/vehicle. Visceral sensitivity was measured as abdominal contractions in response to mechanical intracolonic stimulation 2 hours after cisplatin/vehicle. [Key Results] Cisplatin-induced bedding intake and gastric dysmotility, and granisetron blocked these effects, which occurred in the absence of frank mucositis. Visceral sensitivity was reduced to a similar extent by both drugs alone or in combination. [Conclusions and Inferences] Cisplatin-induced bedding intake and gastric dysmotility were blocked by granisetron, confirming the involvement of serotonin acting on 5-HT3 receptors. Unexpectedly, visceral sensitivity to colonic distension was reduced, to the same extent, by cisplatin, granisetron, and their combination, suggesting important mechanistic differences with nausea and gastric dysmotility that warrant further investigation.
Main Authors: | Martín-Ruíz, Marta, Uranga-Ocio, José Antonio, Mosinska, Paula, Fichna, Jakub, Nurgali, Kulmira, Martín, M. Isabel, Abalo, Raquel |
---|---|
Other Authors: | Ministerio de Ciencia e Innovación (España) |
Format: | artículo biblioteca |
Published: |
John Wiley & Sons
2019
|
Subjects: | Emesis, Pica, Visceral sensitivity, Granisetron, Gastric dysmotility, Cisplatin, |
Online Access: | http://hdl.handle.net/10261/186001 http://dx.doi.org/10.13039/501100004837 http://dx.doi.org/10.13039/100012818 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alterations in the small intestinal wall and motor function after repeated cisplatin in rat
by: Uranga-Ocio, José Antonio, et al.
Published: (2017) -
In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity
by: Roldán-Fidalgo, A., et al.
Published: (2016) -
Involvement of cannabinoid signaling in vincristine-induced gastrointestinal dysmotility in the rat
by: Vera, Gema, et al.
Published: (2017) -
Effects of doxorubicin, cisplatin and tamoxifen on the metabolic profile of human breast cancer MCF-7 cells as determined by ¹H high-resolution magic angle spinning nuclear magnetic resonance.
by: MARIA, R. M., et al.
Published: (2017-11-09) -
Cellular landscaping of cisplatin resistance in cervical cancer
by: Bhattacharjeea, Rahul, et al.
Published: (2022-07-08)